[1]
Lenkiewicz, O. et al. 2026. PLASMA p-tau217 AS A MINIMALLY INVASIVE BIOMARKER FOR ALZHEIMER’S DISEASE DIAGNOSIS: ANALYTICAL PLATFORMS, DIAGNOSTIC PERFORMANCE, AND CLINICAL IMPLEMENTATION CHALLENGES. International Journal of Innovative Technologies in Social Science. 1, 3(51) (Aug. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.6492.